NO20043211L - Imidazo [1,2-a]pyridinderivat - Google Patents

Imidazo [1,2-a]pyridinderivat

Info

Publication number
NO20043211L
NO20043211L NO20043211A NO20043211A NO20043211L NO 20043211 L NO20043211 L NO 20043211L NO 20043211 A NO20043211 A NO 20043211A NO 20043211 A NO20043211 A NO 20043211A NO 20043211 L NO20043211 L NO 20043211L
Authority
NO
Norway
Prior art keywords
imidazo
pyridine derivative
activity
antifungal
solvat
Prior art date
Application number
NO20043211A
Other languages
English (en)
Inventor
Katsuhiro Kawakami
Makoto Takemura
Youichi Kimura
Hisashi Takahashi
Akihiro Kitamura
Ryohei Nakajima
Yuichi Sugimoto
Hiroshi Takeshita
Jun Watanabe
Kazuo Kanai
Tetsunori Fujisawa
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2003/000913 external-priority patent/WO2004068744A1/ja
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO20043211L publication Critical patent/NO20043211L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Legemiddel. En forbindelse representert ved den etterfølgende formel (I), som har antisoppaktivitet innen et omfattende spekter ved hjelp av en ny mekanisme, dvs. 1,6-P-glukansynteseinhibering, og som spesifikt eller selektivt kan utvise slik aktivitet, et salt derav eller et solvat derav; og et antisoppmiddel inneholdende hvilken som helst av disse.
NO20043211A 2002-01-31 2004-07-28 Imidazo [1,2-a]pyridinderivat NO20043211L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002022767 2002-01-31
PCT/JP2003/000913 WO2004068744A1 (ja) 2003-01-30 2003-01-30 光クロスコネクト装置及び光クロスコネクト装置の監視方法

Publications (1)

Publication Number Publication Date
NO20043211L true NO20043211L (no) 2004-10-27

Family

ID=27654429

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043211A NO20043211L (no) 2002-01-31 2004-07-28 Imidazo [1,2-a]pyridinderivat

Country Status (10)

Country Link
US (1) US20050113397A1 (no)
EP (1) EP1479681A4 (no)
JP (1) JPWO2003064422A1 (no)
KR (1) KR20040077920A (no)
CN (1) CN1633434A (no)
CA (1) CA2474850A1 (no)
NO (1) NO20043211L (no)
RU (1) RU2004126320A (no)
TW (1) TW200306822A (no)
WO (1) WO2003064422A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1717238A4 (en) * 2004-02-16 2008-03-05 Daiichi Seiyaku Co FUNGICIDES HETEROCYCLIC COMPOUNDS
US20070155738A1 (en) * 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
BRPI0609802A2 (pt) * 2005-05-20 2017-05-02 Alantos Pharmaceuticals Holding Inc composto, composição farmacêutica e uso de um composto
WO2007020936A1 (ja) 2005-08-17 2007-02-22 Daiichi Sankyo Company, Limited 抗真菌作用二環性複素環化合物
EP1911752A1 (en) * 2006-10-03 2008-04-16 Lonza Ag Process for the preparation of butyrolactones
CA2680587A1 (en) * 2007-03-15 2008-09-25 Schering Corporation Piperazine-substituted pyridazinone derivatives useful as glucan synthase inhibitors
PE20081882A1 (es) 2007-03-15 2008-12-27 Schering Corp Derivados de piridazinona utiles como inhibidores de glucano sintasa
TW201204721A (en) * 2010-04-27 2012-02-01 Astellas Pharma Inc Imidazo [1,2-a] pyridine derivatives
ES2561105T3 (es) 2011-08-18 2016-02-24 Nippon Shinyaku Co., Ltd. Derivado heterocíclico como inhibidor de prostaglandina E sintasa microsómica (mPGES)
EA201792054A1 (ru) 2015-03-18 2018-01-31 Бристол-Майерс Сквибб Компани Гетероциклические соединения, применимые в качестве ингибиторов tnf
MX2017011433A (es) 2015-03-18 2017-11-10 Bristol Myers Squibb Co Compuestos heterociclicos triciclicos utiles como inhibidores del factor de necrosis tumoral (tnf).
BR112017019773A2 (pt) 2015-03-18 2018-05-15 Bristol-Myers Squibb Company compostos heterocíclicos tricíclicos substituídos
US10335392B2 (en) 2015-08-03 2019-07-02 Bristol-Myers Squibb Company Cyclic compounds useful as modulators of TNF α

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
WO2001083733A1 (fr) * 2000-05-01 2001-11-08 Daiichi Pharmaceutical Co., Ltd. Procede de criblage de medicaments agissant sur la paroi cellulaire

Also Published As

Publication number Publication date
WO2003064422A1 (fr) 2003-08-07
EP1479681A4 (en) 2006-05-10
US20050113397A1 (en) 2005-05-26
RU2004126320A (ru) 2005-04-10
TW200306822A (en) 2003-12-01
CN1633434A (zh) 2005-06-29
CA2474850A1 (en) 2003-08-07
KR20040077920A (ko) 2004-09-07
JPWO2003064422A1 (ja) 2005-05-26
EP1479681A1 (en) 2004-11-24

Similar Documents

Publication Publication Date Title
NO331013B1 (no) Nye forbindelser som er anti-inflammasjons, immunomodulerende og anti-proliferative midler, anvendelse av forbindelsene samt farmasoytisk preparat
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
MXPA05009985A (es) Ligandos de receptores de canabinoides.
NO20052884L (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
NO20050828L (no) lndol-3-svovelderivater
NO20045369L (no) Nye, substituerte sulfamatanticonvulsivaderivater
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
NO20043211L (no) Imidazo [1,2-a]pyridinderivat
WO2005021495A3 (en) Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
EP1541570A4 (en) NEW PHYSIOLOGICALLY ACTIVE SUBSTANCE
NO20063576L (no) 1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes
NO20051289L (no) Lincomycinderivater som fremviser antibakteriell aktivitet.
NO20061789L (no) Aminopyridinderivater som induserbare NO-syntaseinhibitorer
DK1483245T3 (da) 5-substituerede alkylaminopyrazolderivater som pesticider
SE0200919D0 (sv) Chemical compounds
WO2000003988A1 (fr) Nouveaux derives de l'acide benzoique et procedes de preparation associes
WO2002024697A1 (fr) Composes spiro et inhibiteurs de molecules d'adhesion contenant ces composes comme ingredient actif
NO20052994L (no) Nye fosforamidderivater.
WO2004067703A3 (en) 5ht7 antagonists and inverse agonists
NO20061343L (no) Imidazo[4,5-b]pyridinderivater som induserbare NO-syntaseinhibitorer
NO20044466L (no) Plasma-karboksypeptidase B-inhibitorer
EP1803719A4 (en) 1,5-DIHETEROCYCLUS-1H-triazole
NO20070421L (no) Radiosensitiviserende middel
ATE373000T1 (de) Pyrazolopyridin-derivate als antiherpesmittel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application